novartis signs up poh's tpm, page-12

Thx Sarto, firstly it looks like POH got in just in time then. As that investment has already been implemented as per ann.

Its more complicated than that too. Novartis were playing the game by doing a minor change to continue patent. Re formulating with TPM for products is probably going to be considered a genuine technological advancement of products for patent protections.

I am trying to get a response together for that poster ABDM regarding the Lux POH thread on the Biotech forum to address his curret views of POHs technology. I am hoping this will be done in a few days.